VanEck Pharmaceutical ETF (PPH) To Go Ex-Dividend on July 1st

VanEck Pharmaceutical ETF (NASDAQ:PPH) announced a quarterly dividend on Tuesday, June 30th, NASDAQ Dividends reports. Stockholders of record on Wednesday, July 1st will be paid a dividend of 0.6248 per share on Tuesday, July 7th. This represents a c) dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date is Wednesday, July 1st.

VanEck Pharmaceutical ETF Price Performance

Shares of NASDAQ PPH opened at $107.95 on Thursday. The company has a 50 day simple moving average of $103.58 and a 200 day simple moving average of $104.87. The firm has a market cap of $1.02 billion, a PE ratio of 20.21 and a beta of 0.47. VanEck Pharmaceutical ETF has a 1 year low of $81.74 and a 1 year high of $112.58.

Hedge Funds Weigh In On VanEck Pharmaceutical ETF

Large investors have recently modified their holdings of the business. AlphaCore Capital LLC bought a new stake in shares of VanEck Pharmaceutical ETF in the fourth quarter worth $31,000. Group One Trading LLC bought a new position in VanEck Pharmaceutical ETF during the 4th quarter worth $36,000. IFP Advisors Inc lifted its holdings in VanEck Pharmaceutical ETF by 53.7% during the 3rd quarter. IFP Advisors Inc now owns 438 shares of the company’s stock worth $40,000 after buying an additional 153 shares during the period. Advisory Services Network LLC acquired a new position in VanEck Pharmaceutical ETF during the 3rd quarter worth about $41,000. Finally, EFG International AG bought a new stake in shares of VanEck Pharmaceutical ETF in the 4th quarter valued at about $44,000.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.